Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001905252-24-000001
Filing Date
2024-12-26
Accepted
2024-12-26 15:51:20
Documents
1
Effectiveness Date
2024-12-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9100
  Complete submission text file 0001905252-24-000001.txt   10185
Mailing Address 1025 ALAMEDA DE LAS PULGAS, SUITE 122 BELMONT CA 94002
Business Address 1025 ALAMEDA DE LAS PULGAS, SUITE 122 BELMONT CA 94002 (858) 357-4137
Solve Therapeutics, Inc. (Filer) CIK: 0001905252 (see all company filings)

EIN.: 863795367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-533368 | Film No.: 241580943